FIELD: medicine.
SUBSTANCE: to predict atypical antipsychotic drug treatment rates in patients with schizophrenia, prior to the initiation of treatment, patient's blood serum is analysed for alanine transferase activity in IU/l. If this value exceeds 25 IU/l, negative atypical antipsychotic drug treatment rates are predicted in the patients with schizophrenia.
EFFECT: extended range of products for prediction of atypical antipsychotic drug treatment rates in the patients with schizophrenia, a facilitated prediction process and reduced length of the prediction process.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF ATYPICAL ANTIPSYCHOTIC DRUG TREATMENT RATES IN SHIZOPHRENICS | 2010 |
|
RU2417377C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATMENT OF PATIENTS WITH SCHIZOPHRENIA | 2021 |
|
RU2775440C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF OLANZAPINE ATYPICAL ANTIPSYCHOTIC DRUG THERAPY IN SCHIZOPHRENIA PATIENTS | 2017 |
|
RU2680529C1 |
| METHOD FOR PREDICTION OF CLINICAL EFFECTIVENESS IN SCHIZOPHRENIC PATIENTS | 2014 |
|
RU2546021C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING PATIENTS WITH SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTIC QUETIAPIN (SEROQUEL) | 2005 |
|
RU2289137C1 |
| PREDICTION METHOD OF THERAPY EFFECTIVENESS IN PATIENTS WITH PAROXYSMAL SCHIZOPHRENIA | 2016 |
|
RU2621266C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF TREATING RESIDUAL SCHIZOPHRENIA WITH ATYPICAL NEUROLEPTICS | 2006 |
|
RU2319155C2 |
| METHOD OF EFFICIENCY FORECAST FOR RESIDUAL SHIZOPHRENIA TREATMENT BY ATYPICAL NEUROLEPTIC QUETIAPINE | 2007 |
|
RU2349918C1 |
| METHOD OF PROGNOSIS OF EFFECTIVENESS OF ENDOGENIC PSYCHOSIS PSYCHOPHARMACOTHERAPY | 1998 |
|
RU2138818C1 |
| METHOD FOR PREDICTION OF EFFICACY OF LADASTEN THERAPY OF ORGANIC ASTHENIC DISORDERS | 2011 |
|
RU2459208C1 |
